SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Oregon on behalf of investors who purchased GNC Holdings Inc. (NYSE:GNC) securities between May 2, 2013 and October 22, 2015.
Click here to learn about the case: http://docs.wongesq.com/GNC-Info-Request-Form-1010. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period, Defendants issued materially false and/or misleading information and/or failed to disclose that: (1) GNC unlawfully sold thousands of units of products in Oregon that contained picamilon; (2) GNC unlawfully sold thousands of units of products in Oregon that contained BMPEA; and (3) as a result of the foregoing, the Company’s public statements were materially false and misleading.
On October 22, 2015, the Oregon Department of Justice filed a lawsuit against GNC Holdings claiming that the company’s nutritional and dietary supplements contain picamilon and BMPEA. Said Attorney General Rosenblum, “It is scary to know that certain products sold by GNC contain an ingredient that is not even labeled—let alone approved in the United States.”
If you suffered a loss in GNC Holdings you have until December 28, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/GNC-Info-Request-Form-1010.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
